These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34031325)

  • 21. Relationship between arterial stiffness and cognitive function in outpatients with dementia and mild cognitive impairment compared with community residents without dementia.
    Hirasawa A; Nagai K; Miyazawa T; Koshiba H; Tamada M; Shibata S; Kozaki K
    J Geriatr Cardiol; 2022 Aug; 19(8):594-602. PubMed ID: 36339473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes.
    Xu G; Meyer JS; Thornby J; Chowdhury M; Quach M
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1027-33. PubMed ID: 12404652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.
    DeCarli C; Mungas D; Harvey D; Reed B; Weiner M; Chui H; Jagust W
    Neurology; 2004 Jul; 63(2):220-7. PubMed ID: 15277612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.
    Panza F; Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Palasciano R; Todarello O; Capurso S; Pellicani V; Capurso A
    Aging Clin Exp Res; 2006 Apr; 18(2):144-8. PubMed ID: 16702784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
    J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
    Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-onset Alzheimer's disease: a global cross-sectional analysis.
    Panegyres PK; Chen HY;
    Eur J Neurol; 2014 Sep; 21(9):1149-54, e64-5. PubMed ID: 24780092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.
    Siuda J; Gorzkowska A; Patalong-Ogiewa M; Krzystanek E; Czech E; Wiechuła B; Garczorz W; Danch A; Jasińska-Myga B; Opala G
    Neurol Neurochir Pol; 2009; 43(4):321-9. PubMed ID: 19742390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease.
    Bennett D
    Int J Clin Pract Suppl; 2001 May; (120):41-8. PubMed ID: 11406925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac disorders as risk factors for Alzheimer's disease.
    de Toledo Ferraz Alves TC; Ferreira LK; Wajngarten M; Busatto GF
    J Alzheimers Dis; 2010; 20(3):749-63. PubMed ID: 20413875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.